Schedule 1 Therapeutics Inc

Biotechnology company · Chicago, Illinois, United States

Schedule 1 Therapeutics Inc is a biotechnology company headquartered in Chicago, Illinois, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.2 million in total, most recently in 2024.

www.s1therapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Schedule 1 Therapeutics at a glance

Typebiotechnology company

HeadquartersChicago, Illinois, United States

Employees (self-reported, 2024)1

What does Schedule 1 Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $3.2 million in total (2020 to 2024). NIH funding came from the National Institute on Drug Abuse.

Frequently asked questions about Schedule 1 Therapeutics

Where is Schedule 1 Therapeutics headquartered?

Schedule 1 Therapeutics Inc is headquartered in Chicago, Illinois, United States.

What does Schedule 1 Therapeutics do?

Schedule 1 Therapeutics Inc is a biotechnology company.

Similar companies

Metame Health Inc.Chicago, Illinois, United States
Synapticure, Inc.Chicago, Illinois, United States
BiomeSense, Inc.Chicago, Illinois, United States
Inomagen Therapeutics, Inc.Chicago, Illinois, United States
Nuago Therapeutics, Inc.Chicago, Illinois, United States
Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
Diagnostic Photonics, Inc.Chicago, Illinois, United States
Microsensor Labs, LLCChicago, Illinois, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences